Phenylimidazolidine derivatives and their use
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 13, 1995
Grant Date -
N/A
app pub date -
Jul 22, 1993
filing date -
Jul 24, 1992
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Phenylimidazolidine derivatives of the general formula I ##STR1## in which, for example, Y denotes --CH.sub.2 --CH.sub.2 --CO-- r denotes 0 to 3 Z denotes oxygen W denotes hydroxyl R.sup.1 denotes --NH--C(.dbd.NH)--NH.sub.2 R, R.sup.2, R.sup.3 denote hydrogen R.sup.4 denotes --CO--NHR.sup.5, where --NH--R.sup.5 represents an .alpha.-amino acid radical, have useful pharmacological properties such as inhibition of platelet aggregation and osteoclast binding to the bone surfaces.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully